Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
Injectable Anticoagulants market report explains the definition, types, applications, major countries, and major players of the Injectable Anticoagulants market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Aspen
Boehringer Ingelheim
Pfizer
Otsuka
Genentech (Roche)
The Medicines Company
Sanofi
By Type:
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
By End-User:
VTE
ACS/MI
AF
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Injectable Anticoagulants Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Injectable Anticoagulants Outlook to 2028- Original Forecasts
-
2.2 Injectable Anticoagulants Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Injectable Anticoagulants Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Injectable Anticoagulants Market- Recent Developments
-
6.1 Injectable Anticoagulants Market News and Developments
-
6.2 Injectable Anticoagulants Market Deals Landscape
7 Injectable Anticoagulants Raw Materials and Cost Structure Analysis
-
7.1 Injectable Anticoagulants Key Raw Materials
-
7.2 Injectable Anticoagulants Price Trend of Key Raw Materials
-
7.3 Injectable Anticoagulants Key Suppliers of Raw Materials
-
7.4 Injectable Anticoagulants Market Concentration Rate of Raw Materials
-
7.5 Injectable Anticoagulants Cost Structure Analysis
-
7.5.1 Injectable Anticoagulants Raw Materials Analysis
-
7.5.2 Injectable Anticoagulants Labor Cost Analysis
-
7.5.3 Injectable Anticoagulants Manufacturing Expenses Analysis
8 Global Injectable Anticoagulants Import and Export Analysis (Top 10 Countries)
-
8.1 Global Injectable Anticoagulants Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Injectable Anticoagulants Export by Region (Top 10 Countries) (2017-2028)
9 Global Injectable Anticoagulants Market Outlook by Types and Applications to 2022
-
9.1 Global Injectable Anticoagulants Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Low-molecular-weight Heparin (LMWH) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Direct Thrombin Inhibitor (DTI) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Injectable Anticoagulants Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global VTE Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ACS/MI Consumption and Growth Rate (2017-2022)
-
9.2.3 Global AF Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Injectable Anticoagulants Market Analysis and Outlook till 2022
-
10.1 Global Injectable Anticoagulants Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Injectable Anticoagulants Consumption (2017-2022)
-
10.2.2 Canada Injectable Anticoagulants Consumption (2017-2022)
-
10.2.3 Mexico Injectable Anticoagulants Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Injectable Anticoagulants Consumption (2017-2022)
-
10.3.2 UK Injectable Anticoagulants Consumption (2017-2022)
-
10.3.3 Spain Injectable Anticoagulants Consumption (2017-2022)
-
10.3.4 Belgium Injectable Anticoagulants Consumption (2017-2022)
-
10.3.5 France Injectable Anticoagulants Consumption (2017-2022)
-
10.3.6 Italy Injectable Anticoagulants Consumption (2017-2022)
-
10.3.7 Denmark Injectable Anticoagulants Consumption (2017-2022)
-
10.3.8 Finland Injectable Anticoagulants Consumption (2017-2022)
-
10.3.9 Norway Injectable Anticoagulants Consumption (2017-2022)
-
10.3.10 Sweden Injectable Anticoagulants Consumption (2017-2022)
-
10.3.11 Poland Injectable Anticoagulants Consumption (2017-2022)
-
10.3.12 Russia Injectable Anticoagulants Consumption (2017-2022)
-
10.3.13 Turkey Injectable Anticoagulants Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Injectable Anticoagulants Consumption (2017-2022)
-
10.4.2 Japan Injectable Anticoagulants Consumption (2017-2022)
-
10.4.3 India Injectable Anticoagulants Consumption (2017-2022)
-
10.4.4 South Korea Injectable Anticoagulants Consumption (2017-2022)
-
10.4.5 Pakistan Injectable Anticoagulants Consumption (2017-2022)
-
10.4.6 Bangladesh Injectable Anticoagulants Consumption (2017-2022)
-
10.4.7 Indonesia Injectable Anticoagulants Consumption (2017-2022)
-
10.4.8 Thailand Injectable Anticoagulants Consumption (2017-2022)
-
10.4.9 Singapore Injectable Anticoagulants Consumption (2017-2022)
-
10.4.10 Malaysia Injectable Anticoagulants Consumption (2017-2022)
-
10.4.11 Philippines Injectable Anticoagulants Consumption (2017-2022)
-
10.4.12 Vietnam Injectable Anticoagulants Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Injectable Anticoagulants Consumption (2017-2022)
-
10.5.2 Colombia Injectable Anticoagulants Consumption (2017-2022)
-
10.5.3 Chile Injectable Anticoagulants Consumption (2017-2022)
-
10.5.4 Argentina Injectable Anticoagulants Consumption (2017-2022)
-
10.5.5 Venezuela Injectable Anticoagulants Consumption (2017-2022)
-
10.5.6 Peru Injectable Anticoagulants Consumption (2017-2022)
-
10.5.7 Puerto Rico Injectable Anticoagulants Consumption (2017-2022)
-
10.5.8 Ecuador Injectable Anticoagulants Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Injectable Anticoagulants Consumption (2017-2022)
-
10.6.2 Kuwait Injectable Anticoagulants Consumption (2017-2022)
-
10.6.3 Oman Injectable Anticoagulants Consumption (2017-2022)
-
10.6.4 Qatar Injectable Anticoagulants Consumption (2017-2022)
-
10.6.5 Saudi Arabia Injectable Anticoagulants Consumption (2017-2022)
-
10.6.6 United Arab Emirates Injectable Anticoagulants Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Injectable Anticoagulants Consumption (2017-2022)
-
10.7.2 South Africa Injectable Anticoagulants Consumption (2017-2022)
-
10.7.3 Egypt Injectable Anticoagulants Consumption (2017-2022)
-
10.7.4 Algeria Injectable Anticoagulants Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Injectable Anticoagulants Consumption (2017-2022)
-
10.8.2 New Zealand Injectable Anticoagulants Consumption (2017-2022)
11 Global Injectable Anticoagulants Competitive Analysis
-
11.1 Aspen
-
11.1.1 Aspen Company Details
-
11.1.2 Aspen Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Aspen Injectable Anticoagulants Main Business and Markets Served
-
11.1.4 Aspen Injectable Anticoagulants Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Boehringer Ingelheim
-
11.2.1 Boehringer Ingelheim Company Details
-
11.2.2 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Boehringer Ingelheim Injectable Anticoagulants Main Business and Markets Served
-
11.2.4 Boehringer Ingelheim Injectable Anticoagulants Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer
-
11.3.1 Pfizer Company Details
-
11.3.2 Pfizer Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer Injectable Anticoagulants Main Business and Markets Served
-
11.3.4 Pfizer Injectable Anticoagulants Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Otsuka
-
11.4.1 Otsuka Company Details
-
11.4.2 Otsuka Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Otsuka Injectable Anticoagulants Main Business and Markets Served
-
11.4.4 Otsuka Injectable Anticoagulants Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Genentech (Roche)
-
11.5.1 Genentech (Roche) Company Details
-
11.5.2 Genentech (Roche) Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Genentech (Roche) Injectable Anticoagulants Main Business and Markets Served
-
11.5.4 Genentech (Roche) Injectable Anticoagulants Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 The Medicines Company
-
11.6.1 The Medicines Company Company Details
-
11.6.2 The Medicines Company Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 The Medicines Company Injectable Anticoagulants Main Business and Markets Served
-
11.6.4 The Medicines Company Injectable Anticoagulants Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sanofi
-
11.7.1 Sanofi Company Details
-
11.7.2 Sanofi Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sanofi Injectable Anticoagulants Main Business and Markets Served
-
11.7.4 Sanofi Injectable Anticoagulants Product Portfolio
-
11.7.5 Recent Research and Development Strategies
12 Global Injectable Anticoagulants Market Outlook by Types and Applications to 2028
-
12.1 Global Injectable Anticoagulants Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Low-molecular-weight Heparin (LMWH) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Direct Thrombin Inhibitor (DTI) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Injectable Anticoagulants Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global VTE Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global AF Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Injectable Anticoagulants Market Analysis and Outlook to 2028
-
13.1 Global Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.2.2 Canada Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.2.3 Mexico Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.2 UK Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.3 Spain Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.4 Belgium Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.5 France Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.6 Italy Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.7 Denmark Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.8 Finland Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.9 Norway Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.10 Sweden Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.11 Poland Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.12 Russia Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.3.13 Turkey Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.2 Japan Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.3 India Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.4 South Korea Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.8 Thailand Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.9 Singapore Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.11 Philippines Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.2 Colombia Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.3 Chile Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.4 Argentina Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.6 Peru Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.6.3 Oman Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.6.4 Qatar Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.7.2 South Africa Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.7.3 Egypt Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.7.4 Algeria Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Injectable Anticoagulants Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Injectable Anticoagulants Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Injectable Anticoagulants
-
Figure of Injectable Anticoagulants Picture
-
Table Global Injectable Anticoagulants Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Injectable Anticoagulants Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Low-molecular-weight Heparin (LMWH) Consumption and Growth Rate (2017-2022)
-
Figure Global Direct Thrombin Inhibitor (DTI) Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global VTE Consumption and Growth Rate (2017-2022)
-
Figure Global ACS/MI Consumption and Growth Rate (2017-2022)
-
Figure Global AF Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Anticoagulants Consumption by Country (2017-2022)
-
Table North America Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure United States Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Canada Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Mexico Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table Europe Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure Germany Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure UK Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Spain Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Belgium Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure France Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Italy Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Denmark Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Finland Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Norway Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Sweden Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Poland Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Russia Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Turkey Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table APAC Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure China Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Japan Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure India Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure South Korea Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Thailand Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Singapore Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Philippines Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table South America Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure Brazil Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Colombia Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Chile Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Argentina Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Peru Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table GCC Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure Bahrain Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Oman Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Qatar Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table Africa Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure Nigeria Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure South Africa Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Egypt Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Algeria Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table Oceania Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure Australia Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table Aspen Company Details
-
Table Aspen Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Injectable Anticoagulants Main Business and Markets Served
-
Table Aspen Injectable Anticoagulants Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Injectable Anticoagulants Main Business and Markets Served
-
Table Boehringer Ingelheim Injectable Anticoagulants Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Injectable Anticoagulants Main Business and Markets Served
-
Table Pfizer Injectable Anticoagulants Product Portfolio
-
Table Otsuka Company Details
-
Table Otsuka Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Injectable Anticoagulants Main Business and Markets Served
-
Table Otsuka Injectable Anticoagulants Product Portfolio
-
Table Genentech (Roche) Company Details
-
Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Injectable Anticoagulants Main Business and Markets Served
-
Table Genentech (Roche) Injectable Anticoagulants Product Portfolio
-
Table The Medicines Company Company Details
-
Table The Medicines Company Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Injectable Anticoagulants Main Business and Markets Served
-
Table The Medicines Company Injectable Anticoagulants Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Injectable Anticoagulants Main Business and Markets Served
-
Table Sanofi Injectable Anticoagulants Product Portfolio
-
Figure Global Low-molecular-weight Heparin (LMWH) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Direct Thrombin Inhibitor (DTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VTE Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AF Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Table North America Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure United States Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure Germany Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure China Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure Brazil Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure Australia Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
